Filing Details
- Accession Number:
- 0001140361-11-022726
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-20 16:33:30
- Reporting Period:
- 2011-04-18
- Filing Date:
- 2011-04-20
- Accepted Time:
- 2011-04-20 16:33:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 897448 | Amarin Corp Plc | AMRN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1397144 | Llp Abingworth | Princes House 38 Jermyn Street London X0 SW1Y 6DN | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, 50 Pence Par Value Per Share | Disposition | 2011-04-18 | 4,179,174 | $14.87 | 7,895,826 | No | 4 | S | Indirect | See Notes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Notes |
Footnotes
- The sales reported in this Form 4 were effected pursuant to pre-arranged stock trading plans (the "Trading Plans") entered into by each of Abingworth Bioventures V L.P., Abingworth Bioventures V Co-Invest Growth Equity Fund LP and Abingworth Bioequities Master Fund Limited (collectively, the "Abingworth Funds") on March 9, 2011. The Trading Plans were designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Abingworth Funds terminated the Trading Plans as of April 18, 2011, following the trades reported herein.
- Abingworth LLP (the "Reporting Person") is the investment manager to a number of investment funds that include the Abingworth Funds. The Reporting Person may be deemed to beneficially own the reported securities indirectly through the Abingworth Funds. The Abingworth Funds sold an aggregate of 4,179,174 ordinary shares, 50 pence par value per share, of Amarin Corporation plc on April 18, 2011.
- The Reporting Person's interest in the securities reported herein is limited to the extent of its pecuniary interest in the Abingworth Funds, if any. This report shall not be deemed an admission that the Reporting Person, each Abingworth Fund or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Exchange Act or for any other purpose.
Billionaire Hedge Funds
